Skip to content

A real-world multicentre study of acetylaconitine tablets in the treatment of chronic pain

A real-world multicentre study of acetylaconitine tablets in the treatment of chronic pain

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070150
Enrollment
Unknown
Registered
2023-04-03
Start date
2023-04-05
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

Patients with chronic pain:Non-intervention

Sponsors

Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Subjects volunteered and signed the informed consent form for the trial; (2) Patients with chronic pain have a history of more than 1 month; VAS is greater than 40mm (3) The patient/legal guardian must be able to read, understand and sign the informed consent form (ICF); (4) Have the ability to understand and complete various scales; (5) Subjects can follow the drug dose and visit plan and cooperate with follow-up, including mobile phone APP follow-up; (6) Patients with contraindications of non-acetylaconitine drugs; (7) No drug abuse or drug addiction; (8) Non-feeding and pregnant women: subjects (including male subjects) without pregnancy plan within 1 month after the trial.

Exclusion criteria

Exclusion criteria: (1) the patient was or is currently participating in or planning to participate in any interventional clinical study 3 months ago; (2) the researcher considered that the patients were not fit to participate in this study; (3) the sponsor or researcher directly involved in the trial or their family members. (4) other aconitines have been taken orally.

Design outcomes

Primary

MeasureTime frame
visual analogue scale, VAS;ID pain;

Secondary

MeasureTime frame
Numeric Pain Rating Scale;Douleur Neuropathique 4 questions,(DN4);Leeds Assessment of Neuropathic Symptoms and Signs, LANSS;Simplified McGill Pain Questionnaire;Pittsburgh Sleep Quality Index;The Patient Health Questionnaire(PHQ-9);Generalized Anxiety Disorder-7(GAD-7);

Countries

China

Contacts

Public ContactKe Ma

Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine

marke72@163.com13361879260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026